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Abstract
Background: Ventricular septal defects (VSD) are the most common subtype of congenital heart defects (CHD) and
are estimated to account for 20 to 30% of all cases of CHD. The etiology of isolated VSD remains poorly
understood. Eight core aminoacyl-tRNA synthetases (ARSs) (EPRS, MARS, QARS, RARS, IARS, LARS, KARS, and DARS)
combine with three nonenzymatic components to form a complex known as the multisynthetase complex (MSC).
Four single nucleotide polymorphisms (SNPs) in EPRS have been reported to be associated with risks of CHD in
Chinese populations.
Methods: In this study, we hypothesize that SNPs of the DARS gene might influence susceptibility to sporadic
isolated VSD. Therefore, we conducted a case-control study of 841 patients with isolated VSD and 2953 non-CHD
controls from the Chinese Han population to evaluate how 4 potentially functional SNPs within the DARS gene
were associated with the risk of VSD.
Results: We observed that the risk of VSD was significantly associated with rs2164331 [G/A; odds ratio (OR) = 0.78,
95% confidence interval (CI) = 0.69-0.91; P = 3.17 × 10-3], rs6738266 [G/A; OR = 1.17, 95% CI = 1.05-1.29, P = 1.83 × 10-
3], and rs309143 [G/A; OR = 1.09, 95% CI = 1.01-1.17; P = 3.12 × 10-2]. Additionally, compared with individuals with 0-2
risk alleles, individuals carrying 3, 4, and 5 or more risk alleles had 1.01-, 1.22- and 1.46-fold greater risks of VSD,
respectively. These findings revealed a significant dose-response effect for VSD risk among individuals carrying
different numbers of risk alleles (Ptrend = 6.37 × 10
-4).
Conclusions: These findings indicate that genetic variants of the DARS gene may influence individual susceptibility
to isolated VSD in the Chinese Han population.
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Background
Congenital heart defects (CHD) are the most common
major human birth malformation, affecting approxi-
mately 8 per 1,000 live births [1, 2]. CHD are associated
with significant morbidity and mortality and are second
only to infectious diseases with respect to contributing
to infant mortality rate [3]. In China, the overall mortal-
ity rate of CHD increased from 141 per 10,000,000
person-years in 2003 to 229 per 10,000,000 person-years
in 2010, a 62.4% relative increase [4]. With the advances
in surgical techniques, the prognosis of children with
complicated and uncomplicated CHDs continues to im-
prove, but the reported incidence remains unchanged
[5]. Ventricular septal defects (VSD) are the most com-
mon subtype of CHD and are estimated to account for
20 to 30% of all CHD [6]. The majority of VSD (~80%)
occur as sporadic events, although certain VSD affect
multiple family members [7].
The etiology of VSD is complex and possibly includes
the interaction of inherited factors and environmental
exposures [8]. A multitude of research studies have iden-
tified both chromosomal abnormality and gene muta-
tions as causation for the syndromic heart malfunction
[9]. However, the origin of isolated VSD is waiting to be
uncovered further [10].
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Over the past decades, plenty of genes have been identi-
fied as candidates to be responsible for VSD [9]. However,
aminoacyl-tRNA synthetases (ARSs) that seemed to be in
charge of only cellular protein synthesis were overlooked
[11, 12]. ARSs catalyze the attachment of amino acids to
their cognate tRNAs with high fidelity [13, 14]. Recent re-
search has shown that eukaryote ARSs, distinguished from
their prokaryotic counterparts, have additional domains
and motifs such as glutathione S-transferase (GST), WHEP
domains, leucine zipper domains, and α-helicalappendices
that function beyond translation [15] and may link with a
variety of human diseases, such as cancer, neuronal path-
ologies, autoimmune disorders, and disrupted metabolic
conditions [16]. Recently, the nontranslational functions of
vertebrate ARSs have been associated with cytoplasmic
forms and nuclear and secreted extracellular forms that im-
pact cardiovascular development pathways [17].
Eight core aminoacyl-tRNA synthetases (ARSs), bifunc-
tional glutamyl-prolyl-tRNA synthetase (EPRS), isoleucyl-
tRNA synthetase (IRS), leucyl-tRNA synthetase (LRS),
methionyl-tRNA synthetase (MRS), glutaminyl-tRNA syn-
thetase (QRS), lysyl-tRNA synthetase (KRS), aspartyl-tRNA
synthetase (DARS), and arginyl-tRNA synthetase (RRS),
form a macromolecular protein complex with three auxil-
iary factors, designated ARS-interacting multifunctional
protein 1 (AIMP1), AIMP2 and AIMP3. This complex is
known as the multisynthetase complex (MSC). The MSC
may act as a depot for ARSs, which could be subsequently
released from the macromolecular complexes to participate
in auxiliary tasks beyond translation [18], generate a chan-
nel for the delivery of tRNAs and help the proofreading of
newly synthesized nuclear tRNAs in the nucleus. Recently,
four single nucleotide polymorphisms (SNPs) in EPRS have
been reported to be associated with risks of congenital
heart disease in Chinese populations [19].
To determine the effects of genetic variants of the DARS
gene on the development of isolated VSD, we conducted a
case-control study that investigated the genotype frequency
distribution of these 4 potentially functional polymorphisms.
Methods
Ethics statement
This study was approved by the institutional review
board (IRB) of Nanjing Medical University and adhered
to the tenets of the Declaration of Helsinki. The design
and performance of the current study involving human
subjects were clearly described in a research protocol.
All participants and/or their parents were volunteered
and completed an informed consent in writing before
taking part in this research.
Subjects
The case-control analysis included 841 affected children
with sporadic isolated VSD and 2953 unrelated non-CHD
controls. Subjects for this study were consecutively re-
cruited from the Affiliated Nanjing Children’s Hospital of
Nanjing Medical University, China, from March 2009 to
May 2016. All isolated VSD patients were diagnosed based
on echocardiography, with some diagnoses further con-
firmed by cardiac catheterization and/or surgery diagnosed
based on surgery. Cases that had multiple major develop-
mental anomalies, including developmental syndromes, or
known chromosomal abnormalities were excluded. The
exclusion criteria also included a positive family history of
CHD in a first-degree relative (parents, siblings and
children), phenylketonuria, maternal diabetes mellitus,
maternal teratogen exposure (e.g., pesticides and organic
solvents), and maternal therapeutic drug exposure during
the intrauterine period. Controls were non-CHD outpa-
tients from the same geographic areas and same time
period. For each participant, approximately 4 ml of whole
blood was obtained to extract genomic DNA for genotyp-
ing analysis.
SNP selection and Sanger sequencing
For the DARS gene, we first used the public HapMap
single nucleotide polymorphism (SNP) database (phase II +
III, Feb 09, on NCBI B36 assembly and dbSNP b126) to
search for SNPs localized within gene regions with MAF ≥
0.05 in the Chinese Han population. Subsequently, a web-
based analysis tool was used to predict the function of these
SNPs (https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.php).
Finally, a total of 8 potentially functional SNPs were se-
lected. We next conducted linkage disequilibrium (LD) ana-
lysis using Haploview 4.2 software (Broad Institute of MIT
and Harvard, Boston, MA), and 4 SNPs were selected in
cases involving multiple SNPs in the same haplotype
block (r2 > 0.8). Four SNPs (rs2164331, rs6738266, rs309142
and rs309143) remained.
Primers were designed using Primer-BLAST. Variant-
containing PCR products were directly sequenced using
a nested primer (ACGT, Inc., Germantown, MD). Se-
quence data were analyzed using FinchTV.
Statistical analyses
The differences between the VSD patients and control sub-
jects were evaluated in the distributions of selected variables,
and frequencies of genotypes of the four polymorphisms
using Student’s t-test (for continuous variables) or the Chi-
Table 1 Distributions of select variables in VSD cases and non-
CHD controls
Variables Cases(N = 841) Controls(N = 2953) P
Age, years (mean ± s.d.) 1.51 ± 2.23 1.46 ± 2.07 0.544
Gender
Male 409(48.63%) 1453(49.20%) 0.77
Female 432(51.37%) 1500(50.80%)
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square test (for categorical variables). The Chi-square test
determined the Hardy-Weinberg equilibrium of the geno-
type distribution of polymorphisms in the control group.
LD between SNPs was evaluated using Haploview 4.2.
Odds ratios (ORs) and 95% confidence intervals (CIs) were
estimated by logistic regression analyses in the additive
model to estimate the associations between the variants
genotypes and risk of VSD. All statistical analyses were
performed using the Statistical Analysis System software
(v.9.1.3; SAS Institute, Cary, NC, USA). All tests were two-
sided, and P < 0.05 was considered significant.
Results
We systematically investigated the association of poten-
tially functional SNPs with VSD susceptibility in 841
cases and 2953 controls in a Chinese population. There
were no statistically significant differences between the
cases and controls with respect age and gender distribu-
tions (P = 0.544 and P = 0.77, respectively) (Table 1).
The genotype distributions of the four SNPs and their
associations with VSD risk are summarized in Table 2.
The observed genotype frequencies of these SNPs were
in agreement with Hardy-Weinberg equilibrium in the
controls (P values between 0.37 and 0.52). Among the
four SNPs, rs2164331, rs6738266, and rs309143 were
significantly associated with VSD risk based on logistic
regression analysis in the additive model. The A allele of
rs2164331 was associated with a decreased risk of VSD
[additive model: OR = 0.78, 95% CI = 0.69-0.91, P =
3.17 × 10-3]; however, the A allele of rs6738266 and the
G allele of rs309143 were associated with an increased
risk of VSD (OR = 1.17, 95% CI = 1.05-1.29, P = 2.83 ×
10-3, and OR = 1.09, 95% CI = 1.01-1.17, P = 3.12 × 10-2,
respectively). Additionally, we performed haplotype ana-
lysis. As indicated in Table 3, the haplotype “GAG” (the
combination of the risk alleles of the three SNPs) was
associated with an increased risk of VSD, whereas the
protective allele combination “AGA” was associated with
a decreased risk of VSD.
We also conducted a combined analysis of the four
promising SNPs to test their joint effects on VSD risk.
There was a significant dose-response effect with respect
to VSD risk among individuals carrying different numbers
of risk alleles (Ptrend = 6.37 × 10
-4). Compared with individ-
uals with 0-2 risk alleles, those carrying 3, 4 or 5 or more
risk alleles had 1.01-, 1.22- or 1.46-fold greater risks of
VSD, respectively (Table 4).
Discussion
In this study, we systematically investigated how four po-
tentially functional SNPs in one ARS-coding gene, DARS,
were associated with isolated VSD susceptibility in 841
cases and 2953 controls from a Chinese population. We ob-
served that three SNPs (rs2164331, rs6738266, rs309143) in
the DARS gene were significantly associated with the risk of
VSD, which was remarkably elevated in individuals who
carried more risk alleles. Although VSD are the most com-
mon congenital heart malfunctions, the pathogenesis of
these defects is poorly understood, particularly for isolated
VSD. Based on prior research, SNPs in EPRS, another core
coding gene in the MSC, may modulate the process of
CHD in the Chinese Han population [19]. In the present
study, we provided evidence that SNPs in DARS might play
important roles in isolated VSD.
DARS (MIM 603084, RefSeq accession number
NM_001349.2) encodes an aspartyl-tRNA synthetase
(AspRS) [20]. Mutations in this gene have been found
in patients who exhibit hypomyelination with brainstem
and spinal cord involvement and leg spasticity [21, 22].
Homsy et al. [23] used exome sequencing analysis in 1,213
CHD parent-offspring trios to identify several protein-
damaging de novo mutations, particularly in genes that are
highly expressed in the developing heart and brain. They
identified mutations that accounted for 20% of patients
Table 2 Summary of associations between 4 SNPs of DARS gene with VSD
Chr. Gene SNP Allelea MAFb HWEc Additive model
(cytoband) Cases Controls OR (95% CI) P
1q41 DARS rs2164331 G/A 0.22 0.26 0.37 0.78 (0.69-0.91) 3.17 × 10-3
rs6738266 G/A 0.06 0.03 0.52 1.17 (1.05-1.29) 2.83 × 10-3
rs309143 A/G 0.23 0.22 0.41 1.09 (1.01-1.17) 3.12 × 10-2
rs309142 A/G 0.43 0.43 0.29 1.01 (0.91-1.12) 9.11 × 10-1
aMajor/minor allele
bMinor allele frequency among cases/controls
cHardy-Weinberg equilibrium test among controls
Table 3 The haplotypic association of the four SNPs of the
DARS gene with VSD
Haplotypea Case (%) Control (%) OR (95% CI) P
GGA 712(42.33) 2551(43.19) 1.00(referent)
GGG 562(33.41) 1893(32.05) 1.06(0.94-1.21) 3.35 × 10-1
AAG 94(5.59) 289(4.89) 1.17(0.91-1.49) 2.24 × 10-1
GAG 90(5.35) 248(4.20) 1.30(1.01-1.68) 4.30 × 10-2
AGA 140(8.32) 681(11.53) 0.74(0.60-0.90) 3.00 × 10-3
Others 84(4.99) 244(4.13) 1.23(0.95-1.60) 1.15 × 10-1
aSNP order: rs2164331, rs6738266, rs309143
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with CHD, neurodevelopmental disabilities (NDD) and
other congenital anomalies (CA), suggesting that CHD,
NDD, and other CA may share genetic characteristics.
Based on its expressed sequence tag (EST) profile in the
public database UniGene (http://www.ncbi.nlm.nih.gov/
UniGene), the DARS gene is expressed in human heart tis-
sue at a level of 147 transcripts per million.
Transcription factors are known to play a fundamental
role in all stages of heart development, including cardiac
lineage determination, chamber formation, valvulogen-
esis and septation [24]. All three of the significant SNPs
are located in transcription factor binding sites and
could therefore affect binding between transcription fac-
tors and DARS. According to the online tool SNPinfo,
the SNP rs6738266 is an exonic splicing enhancer (ESE)
[25]. The mutation of ESE motifs significantly contrib-
utes to genetic disorders and certain cancers. Simple
point mutations in ESEs can inhibit affinity for splicing
factors and alter alternative splicing, leading to altered
mRNA sequences and protein translation [26].
Several limitations of the present study need to be ad-
dressed. First, we did not replicate the results in add-
itional individuals; this may contribute to potential false
positive errors. The present analysis was restricted to in-
dividuals of Chinese Han descent, and therefore, the
findings may not hold true for individuals of other races
and ethnicities. Additionally, the limited sample size may
have contributed to the weak statistical power of this
study; thus, further replication of the association signal
in an independent cohort for the three SNPs would sup-
port the study’s conclusions. Therefore, the results are
required to be further replicated by well-designed stud-
ies in additional large-scale Chinese Han populations.
Conclusion
In conclusion, we conducted a case-control study to in-
vestigate the roles of genetic variants in one ARS-
coding gene, DARS, in the development of isolated VSD
in a Chinese population. We observed that three SNPs
(rs2164331, rs6738266, and rs309143) may confer suscep-
tibility to sporadic isolated VSD and that risk significantly
increased with the number of risk alleles. However, further
studies involving functional evaluations are warranted to
elucidate the potential biological mechanisms of these
polymorphisms in the development of VSD.
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